The Accessible Canada Directorate within Employment and Social Development Canada (ESDC) has engaged Quorus Consulting Group to conduct the second cycle of public opinion research measuring Canadians’ awareness and experience(s) […]

A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]

Denosumab (Prolia) has been shown to reduce the risk of fracture in postmenopausal women and men ≥50 years old with osteoporosis. It has also been approved for steroid induced bone […]

A number of recent medical reports have linked high doses of intravenous bisphosphonates given to patients for the treatment of multiple myeloma, breast cancer or other cancers, to a condition […]

If you are on medication for osteoporosis, are you ever tempted to stop taking it? If your answer is yes, you are not alone. Studies indicate that especially for those […]

Introducing a fashion line inspired by the two million Canadians affected by osteoporosis TORONTO, Feb. 6, 2019  – Models clad in stylish bubble wrap strutted down the Toronto Fashion Week® x […]

Osteoporosis Canada is saddened to announce the passing of Dr. Timothy M. Murray, founding member of Osteoporosis Canada. Dr. Murray was the Emeritus Professor of Medicine at the University of […]

Christine Thomas was only 42 when, bending to lift her newborn daughter, she fractured her spine. Diagnosed with five vertebral fractures as a result of unsuspected osteoporosis, she had no idea of the painful and transformative road she would have to travel to build stronger bones and reclaim her life.

Aliya Khan, Heather Frame,  Claudia Gagnon,  Rowena Ridout , Lianne Tile,  Wendy Ward, Sandra Kim Recently Duerksen and colleagues published on fracture risk assessment in celiac disease – a registry-based […]